VCNX vs. AIMD, ATXI, XBIO, FWBI, HOTH, ADXS, KZIA, SHPH, ENVB, and IBIO
Should you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Ainos (AIMD), Avenue Therapeutics (ATXI), Xenetic Biosciences (XBIO), First Wave BioPharma (FWBI), Hoth Therapeutics (HOTH), Ayala Pharmaceuticals (ADXS), Kazia Therapeutics (KZIA), Shuttle Pharmaceuticals (SHPH), Enveric Biosciences (ENVB), and iBio (IBIO). These companies are all part of the "pharmaceutical preparations" industry.
Ainos (NASDAQ:AIMD) and Vaccinex (NASDAQ:VCNX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, community ranking, dividends, earnings, institutional ownership and analyst recommendations.
Ainos has higher earnings, but lower revenue than Vaccinex. Ainos is trading at a lower price-to-earnings ratio than Vaccinex, indicating that it is currently the more affordable of the two stocks.
Vaccinex has a net margin of 0.00% compared to Vaccinex's net margin of -11,205.49%. Vaccinex's return on equity of -47.96% beat Ainos' return on equity.
Vaccinex received 123 more outperform votes than Ainos when rated by MarketBeat users.
In the previous week, Vaccinex had 1 more articles in the media than Ainos. MarketBeat recorded 2 mentions for Vaccinex and 1 mentions for Ainos. Vaccinex's average media sentiment score of 1.00 beat Ainos' score of 0.00 indicating that Ainos is being referred to more favorably in the media.
Ainos has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. Comparatively, Vaccinex has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.
50.1% of Vaccinex shares are held by institutional investors. 4.6% of Ainos shares are held by company insiders. Comparatively, 51.5% of Vaccinex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
Ainos and Vaccinex tied by winning 7 of the 14 factors compared between the two stocks.
Get Vaccinex News Delivered to You Automatically
Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vaccinex Competitors List
Related Companies and Tools
